Down 3.8% today, more than its diagnostic peers' 3.4%; no story names it yet.
Fell 17% since Oct 28
Down 17% from Oct 28 to Nov 10.
FTRE's Quality Score fell 2 points on Tue, Nov 10, to 7. It did not trade higher than the day before (2 chart checks stopped).
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
| Since its 2024 high | Down 45% |
| Latest filing | 10-Q, Oct 29 |
TodayNo story names it yet.
Tue Nov 17: Jefferies 17th Annual London Global…Investor conference · date confirmed.
After its last 4 reports it closed +2.8% on average, higher 2 of 4 times.
Averagefor quality, not price, 3 of 14 chart checks firingWhat the Quality Score means
Well below its recent run. FTRE scores 7 today, against a median of 11 over its last 20 recorded sessions.
FTRE is #10 of 18 by Quality Score.
| Rank | Stock | Quality Score |
|---|---|---|
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| 10 |
Expected to report Thu Feb 25, before the open (in 107 days).
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
Sales of $691.5M, 1% less than a year ago.
| Line | Q3 2026 | Q2 2026 | Q3 2025 |
|---|---|---|---|
| North America | $326M | $320M | $333M |
Each quarter's sales and their share of its total. Figures as filed (SEC filing, Oct 29)
| Measure | Figure |
|---|---|
| Revenues | $2.665B to $2.690B |
Sales fell 1.4% a year over 3 years, fiscal 2022 to 2025.
| Reported | Gap | Reaction | 5 days |
|---|---|---|---|
| Oct 29, 2026 | -8.7% | -10.6% | -19.5% |
| Jul 29, 2026 | -5.4% | -1.4% | -13.1% |
| May 5, 2026 | +14.0% | +18.6% | +22.4% |
| Feb 26, 2026 | -9.7% | +4.5% | +0.4% |
Sales grew in two of the last four years, to $2.7B in 2025. It made a profit in two of the five years.
RSI 48.5, MACD below signal, above both averages. Not scored.
6 insiders sold $4.5M across 12 filings in the last 6 months. No open-market buys on record. The newest:
One trade disclosed in the last six months. The newest:
Officers and directors with a Form 4 in the last 12 months.
In ETFs: FTRE is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.
“Our operations in the drug development services industry involve high levels of competition, consisting of hundreds of small, limited-scope service providers, and a smaller number of large full-service drug development companies.”
FTRE scores 7 today, which Breakaway calls Average. It is #10 of 18 in Services-Medical Laboratories by Quality Score, with 3 of 14 chart checks firing. Down 17% from Oct 28 to Nov 10. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
FTRE scores 7 today, which Breakaway calls Average (6 to 10). That is #10 of 18 in Services-Medical Laboratories by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind FTRE's 7.
6 insiders sold $4.5M across 12 filings in the last 6 months. No open-market buys on record. The newest is Mark A. Morais, Chief Operating Officer, who sold $53K on Sep 9. Every filing, with the scored weight, for Pro members.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Insider and Congress trades, the chart, and the financials, in one score.
See it live, free until Thursday morning. No account. No card. Then keep going with a free account.